Skip to main content
. Author manuscript; available in PMC: 2016 Jan 20.
Published in final edited form as: J Stem Cell Res Ther. 2015 Jul 16;5(7):292. doi: 10.4172/2157-7633.1000292

Figure 2.

Figure 2

Marker expression by heterogeneous PDLSCs. (A) Immunocytofluorescence staining of STRO-1, CD73, CD90, CD106 and CD146. Subconfluent cells were all at passage 1. Scale bars: (A) 50 μm for all marker genes and isotype control (Ctrl). (B) Flow cytometry analysis of cell surface markers and the percentage of positive cells with marker expression in the heterogeneous PDLSC population at passage 3 (red peak: control; green peak: specific antibody detection).